| 中文名 | 3,4-二氢-2,6-萘啶-1(2H)-酮 |
|---|---|
| 英文名 | 3,4-dihydro-2H-2,6-naphthyridin-1-one |
| 英文别名 |
1,2,3,4-tetrahydro-2,6-naphthyridin-1-one
1,2,3,4-TETRAHYDRO-2,6-NAPHTHYRIDIN-1-ONE 3,4-dihydro-2H-[2,6]naphthyridin-1-one 3,4-dihydro-2,6-naphthyridin-1(2H)-one 3,4-Dihydro-2H-[2,6]naphthyridin-1-one Tetrahydro-2,6-naphthyridin-1-on 1,2,3,4-Tetrahydro-2,6-naphthyridin-1-on |
| 分子式 | C8H8N2O |
|---|---|
| 分子量 | 148.16200 |
| 精确质量 | 148.06400 |
| PSA | 41.99000 |
| LogP | 0.69630 |
|
~27%
58553-56-3 |
| 文献:NOVARTIS AG; Bock, Mark Gary; Gaul, Christoph; Gummadi, Venkateshwar Rao; Moebitz, Henrik; Sengupta, Saumitra Patent: US2014/45872 A1, 2014 ; Location in patent: Paragraph 1018 ; |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:NOVARTIS AG; BOCK, Mark G.; GAUL, Christoph; GUMMADI, Venkateshwar Rao; MOEBITZ, Henrik; SENGUPTA, Saumitra Patent: WO2012/35078 A1, 2012 ; WO 2012/035078 A1 |
|
~%
58553-56-3 |
| 文献:Meiji Seika Kaisha, Ltd. Patent: EP1180514 A1, 2002 ; Location in patent: Example 104 ; |